citalopram has been researched along with sch 23390 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feltmann, K; Gertow, J; Ivanov, V; Jardemark, K; Konradsson-Geuken, A; Marcus, MM; Schilström, B; Svensson, TH | 1 |
| Björkholm, C; Frånberg, O; Jardemark, K; Konradsson-Geuken, Å; Malmerfelt, A; Marcus, MM; Schilström, B; Svensson, TH | 1 |
| Białoń, M; Hereta, M; Kamińska, K; Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
3 other study(ies) available for citalopram and sch 23390
| Article | Year |
|---|---|
Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.
Topics: Action Potentials; Analysis of Variance; Animals; Benzazepines; Citalopram; Cognition; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Neurons; Neuropsychological Tests; Patch-Clamp Techniques; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Ventral Tegmental Area | 2011 |
Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Topics: Animals; Antipsychotic Agents; Benzazepines; Bicuculline; Biogenic Monoamines; Citalopram; Dibenzocycloheptenes; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; GABA-A Receptor Antagonists; Glutamic Acid; Heterocyclic Compounds, 4 or More Rings; Male; Neurons; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Time Factors | 2014 |
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Aripiprazole; Benzazepines; Biogenic Monoamines; Citalopram; Dizocilpine Maleate; Dopamine Antagonists; Frontal Lobe; Memory Disorders; Piperazines; Pyridines; Rats; Recognition, Psychology; Serotonin Antagonists | 2020 |